By studying seismographs from the earthquake that hit Chile last February, earth scientists at the Georgia Institute of Technology have found a statistically significant increase of microearthquakes in central California in the first few hours after…
BUFFALO, N.Y. — Researchers at the University at Buffalo have devised two new ways of “stapling” peptide helices to prevent these medically important molecules from losing their shape and degrading in the presence of enzymes.
The discovery could h…
Scratching deep beneath the surface, a team of researchers from the University of California, San Diego School of Medicine and three South Korean institutions have identified two distinct neuronal signaling pathways activated by a topical cream used…
Australian researchers have come one step closer to understanding how the rhythm of the heartbeat is controlled and why many common drugs, including some antibiotics, antihistamines and anti-psychotics, can cause a potentially fatal abnormal heart r…
Cambridge, MASS. — Researchers at MIT and Brigham and Women’s Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cel…
BOSTON — A noninvasive electric stimulation technique administered to both sides of the brain can help stroke patients who have lost motor skills in their hands and arms, according to a new study led by researchers at Beth Israel Deaconess Medical …
When it comes to gambling, many people rely on game theory, a branch of applied mathematics that attempts to measure the choices of others to inform their own decisions. It’s used in economics, politics, medicine — and, of course, Las Vegas. But re…
A large international study aimed at improving the care of muscular dystrophy patients worldwide is being launched by physicians, physical therapists, and researchers at the University of Rochester Medical Center.
Neurologist Robert “Berch” Griggs…
Two commonly prescribed epilepsy drugs have varied cognitive side effects on patients, report doctors from Georgetown University Medical Center. Their findings are published in the May 13 issue of the journal Neurology. In a double-blind, randomized study, researchers looked at 2 drugs, valproate–released in 1978 for the treatment of epileptic seizures, and topiramate, approved by the FDA in late 1996. Each drug was added to carbamazepine, a standard epilepsy treatment, and then given to patients with epilepsy. The cognitive effects on those patients taking topiramate were slightly, although noticeably, worse than those taking the older valproate for a subset of patients.
Attempting to resolve a long-standing controversy, UCSF researchers have shown that people suffering from chronic pain due to nervous system damage ? known as neuropathic pain — improved significantly after an eight-week course of the morphine-like medication levorphanol. Neuropathic pain affects about three million people in the U.S., and is considered very difficult to treat.